Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$174.81 - $241.14 $3.77 Million - $5.2 Million
-21,565 Reduced 87.79%
2,998 $706,000
Q1 2022

May 16, 2022

SELL
$166.16 - $213.96 $5.86 Million - $7.55 Million
-35,275 Reduced 58.95%
24,563 $4.41 Million
Q4 2021

Feb 14, 2022

SELL
$184.32 - $216.08 $18.1 Million - $21.2 Million
-98,000 Reduced 62.09%
59,838 $12.9 Million
Q3 2021

Nov 15, 2021

SELL
$179.86 - $214.88 $224,645 - $268,385
-1,249 Reduced 0.79%
157,838 $29.1 Million
Q2 2021

Aug 16, 2021

SELL
$170.47 - $211.93 $68 Million - $84.6 Million
-399,075 Reduced 71.5%
159,087 $28.5 Million
Q1 2021

May 17, 2021

BUY
$153.94 - $174.85 $4.49 Million - $5.11 Million
29,198 Added 5.52%
558,162 $93.4 Million
Q4 2020

Feb 16, 2021

BUY
$101.87 - $151.79 $53.9 Million - $80.3 Million
528,964 New
528,964 $80.3 Million
Q2 2020

Aug 14, 2020

SELL
$92.74 - $125.82 $125 Million - $170 Million
-1,350,360 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$79.39 - $115.35 $34.2 Million - $49.7 Million
431,097 Added 46.9%
1,350,360 $128 Million
Q4 2019

Feb 14, 2020

SELL
$78.31 - $95.34 $3.78 Million - $4.61 Million
-48,306 Reduced 4.99%
919,263 $81 Million
Q3 2019

Nov 14, 2019

BUY
$74.85 - $85.99 $14.7 Million - $16.9 Million
196,800 Added 25.53%
967,569 $77.2 Million
Q2 2019

Aug 14, 2019

SELL
$76.06 - $120.81 $34.6 Million - $54.9 Million
-454,618 Reduced 37.1%
770,769 $60.2 Million
Q1 2019

May 15, 2019

BUY
$107.15 - $126.84 $13.4 Million - $15.8 Million
124,790 Added 11.34%
1,225,387 $144 Million
Q4 2018

Feb 14, 2019

BUY
$101.4 - $128.73 $24.2 Million - $30.7 Million
238,302 Added 27.64%
1,100,597 $120 Million
Q3 2018

Nov 14, 2018

BUY
$113.81 - $129.46 $33.6 Million - $38.2 Million
295,369 Added 52.1%
862,295 $110 Million
Q1 2018

May 15, 2018

BUY
$107.21 - $151.94 $60.8 Million - $86.1 Million
566,926 New
566,926 $63.7 Million

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.3B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Consonance Capital Management LP Portfolio

Follow Consonance Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Consonance Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Consonance Capital Management LP with notifications on news.